Literature DB >> 34570254

A DFT calculation on nonenzymatic degradation of isoaspartic residue.

Wichien Sang-Aroon1, Ratchanee Phatchana2, Sarawut Tontapha3, Vithaya Ruangpornvisuti4.   

Abstract

βAsp is an isomer of Asp that can be formed by either deamidation of Asn or isomerization of Asp and known as biological clock. The presence of βAsp affects the proteolytic stability of the protein. Formation of the isomerized Asp plays a diverse and crucial role in aging, cancer, autoimmune, neurodegenerative, and other diseases. A number of methods have been developed to detect βAsp, and they are usually used in conjunction. Because of identical mass, differentiation of βAsp and Asp residues is challenged. Degradation of βAsp is still unclear and needed to be explored. The energetics and mechanism of five possible pathways for cleavages at βAsp in peptide model have been investigated by DFT/B3LYP/6-311 +  + G(d,p) level of the theory. The calculations show that peptide bond cleavage at α-chain (amino side) due to αOC → αCN ring closure is the most favorable reaction. The result is in agreement with experiment utilizing PSD/CRF method. The second most favorable pathway is due to αOC → βC ring closure results in β-chain cleavage. The cleavage products βAsp and Asp fragments can be used to signify an abundance of βAsp residue in nonenzymatic condition. Other three cyclizations initiated by either α- or β-amino nitrogen result in various cleavages, isomerization to Asp, and reconversion to original βAsp. These three cyclization pathways are obstructed because they require mostly high activation barriers and their intermediates are quite less thermodynamically stable. Thus, computational results also confirm that βAsp → Asp is prohibited in case of nonenzymatic condition which means that protein L-isoaspartyl O-methyl transferase (PIMT) is needed for this modification.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cyclization; Density functional theory; Isoaspartic residue; Isomerization; Peptide bond cleavage

Mesh:

Substances:

Year:  2021        PMID: 34570254     DOI: 10.1007/s00894-021-04920-z

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  23 in total

1.  The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age.

Authors:  M I Fonseca; E Head; P Velazquez; C W Cotman; A J Tenner
Journal:  Exp Neurol       Date:  1999-06       Impact factor: 5.330

Review 2.  Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals?

Authors:  K J Reissner; D W Aswad
Journal:  Cell Mol Life Sci       Date:  2003-07       Impact factor: 9.261

Review 3.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

4.  Spontaneous formation of L-isoaspartate and gain of function in fibronectin.

Authors:  Flavio Curnis; Renato Longhi; Luca Crippa; Angela Cattaneo; Eleonora Dondossola; Angela Bachi; Angelo Corti
Journal:  J Biol Chem       Date:  2006-10-02       Impact factor: 5.157

Review 5.  Damaged proteins bearing L-isoaspartyl residues and aging: a dynamic equilibrium between generation of isomerized forms and repair by PIMT.

Authors:  Richard R Desrosiers; Irvens Fanélus
Journal:  Curr Aging Sci       Date:  2011-02

6.  Neighboring side chain effects on asparaginyl and aspartyl degradation: an ab initio study of the relationship between peptide conformation and backbone NH acidity.

Authors:  J L Radkiewicz; H Zipse; S Clarke; K N Houk
Journal:  J Am Chem Soc       Date:  2001-04-18       Impact factor: 15.419

7.  Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins.

Authors:  M J Mamula; R J Gee; J I Elliott; A Sette; S Southwood; P J Jones; P R Blier
Journal:  J Biol Chem       Date:  1999-08-06       Impact factor: 5.157

8.  Asparagine deamidation perturbs antigen presentation on class II major histocompatibility complex molecules.

Authors:  Catherine X Moss; Stephen P Matthews; Douglas J Lamont; Colin Watts
Journal:  J Biol Chem       Date:  2005-03-04       Impact factor: 5.157

9.  Succinimide formation from aspartyl and asparaginyl peptides as a model for the spontaneous degradation of proteins.

Authors:  R C Stephenson; S Clarke
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

10.  Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.

Authors:  A E Roher; J D Lowenson; S Clarke; C Wolkow; R Wang; R J Cotter; I M Reardon; H A Zürcher-Neely; R L Heinrikson; M J Ball
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.